U.S. Healthtech Stock News

There's been a notable change in appetite for Coda Octopus Group, Inc. ( NASDAQ:CODA ) shares in the week since its...

Dillard's has recently reported disappointing same-store sales and a decline in earnings per share over the past few years, underscoring weaker customer demand and slower growth in its department store business. This pattern of softer sales and earnings suggests the retailer may be contending with shifting consumer preferences and operational pressures that challenge its traditional model. We’ll now examine how Dillard’s weaker same-store sales performance shapes the company’s broader...

TFS Financial (TFSL) has drawn investor attention after a recent move in its share price, with the stock closing at $16.42. That shift is prompting a closer look at recent returns and fundamentals. See our latest analysis for TFS Financial. For context, TFS Financial’s recent move to $16.42 comes after a 22.63% 90 day share price return and a 40.10% 1 year total shareholder return, suggesting momentum has been building over both shorter and longer periods. If this kind of steady progress has...

We wouldn't blame Huntington Bancshares Incorporated ( NASDAQ:HBAN ) shareholders if they were a little worried about...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

With the Federal Reserve shifting toward a more hawkish tone, short term bond and cash equivalent funds are suddenly back in focus for investors who care about capital preservation and liquidity. The latest signals, including a possible rate hike and a “higher for longer” outlook in the dot plot, change how cash, money markets, and ultra short bond exposure may fit into a portfolio. This article breaks down what that shift could mean and walks through 3 stocks from the screener that appear...

Expensify (EXFY) is drawing fresh attention after launching Expensify MCP, a new integration that lets AI assistants like ChatGPT and Claude query expense data in plain language directly from customer accounts. See our latest analysis for Expensify. That MCP launch comes as Expensify’s short term momentum has picked up, with a 30% 1 day share price return and an 86.89% 90 day share price return, even though the 1 year total shareholder return is down 30.04%. If this AI driven move has your...

Spotify Technology (NYSE:SPOT) is expanding its podcast advertising tools with episode-level brand suitability and contextual pre-bid targeting. The company is working with Integral Ad Science and Barometer to add third-party verification and more granular controls for programmatic podcast ads. These capabilities are being introduced across major programmatic platforms, including The Trade Desk. Spotify Technology has been building out its podcast business as a key part of its broader audio...

If you are wondering whether Chemed is attractively priced or still has room to fall, the recent mix of returns and valuation signals gives you plenty to think about. The stock last closed at US$436.27, with a gain of 3.7% over the past week, a slight decline of 0.9% over the last month, and returns of 2.9% year to date but a decline of 19.7% over the past year. These moves put Chemed on the radar for investors who are reassessing what a fair price might look like after a period of weaker...

CTS Corporation (NYSE:CTS) has introduced the TSX Crystal with Integrated Thermistor, expanding its crystal product line. The TSX Crystal is the company’s first crystal resonator that combines real-time temperature feedback with frequency control in a single package. This launch targets applications that require tight frequency stability and compact design in sectors such as telecommunications, automotive, medical devices, and industrial instrumentation. CTS Corporation operates across a...

Gilat Satellite Networks, NasdaqGS:GILT, has agreed to acquire most of Comtech Telecommunications’ Satellite & Space Communications segment. The deal is expected to lift combined annual revenue above $700 million and more than double Gilat’s defense related revenues. The transaction is planned to close by the end of 2026, subject to customary approvals and conditions. Gilat Satellite Networks is moving through this acquisition from a position of recent share price strength, with the stock...

Cepheid, a Danaher subsidiary, has rapidly deployed new diagnostic tests in response to an Ebola outbreak, expanding access to frontline public health tools. IDBS, another Danaher business, has partnered with Alchemi to apply AI to biopharma data management, aiming to speed up regulatory filings. Together, these updates highlight NYSE:DHR using its portfolio to address urgent health threats and regulatory bottlenecks, beyond typical financial headlines. Danaher, trading on the NYSE under...

Orion Group Holdings recently reported stronger earnings, revenue growth, and operational resilience in its marine and infrastructure construction businesses, drawing increased market attention. The company’s continued operational improvement highlights how disciplined execution in specialized construction services can reshape perceptions of its longer-term business strength. We will now examine how Orion Group Holdings’ improved earnings performance and operational resilience may influence...

With Federal Reserve Chair Kevin Warsh taking a tougher line on inflation and traders rapidly adjusting rate expectations, the US dollar has moved back to center stage for equity investors. A stronger dollar can reshape cost structures, import bills, and profit margins in ways that are not always obvious from the share price alone. This article looks at how the latest policy signals and yield moves connect to companies that could be helped by a firm US dollar. Ahead, you will see 3 stocks...

Event driven interest around Playtika Holding stock Playtika Holding (PLTK) is drawing fresh attention after announcing a Bingo Blitz collaboration with Where’s Waldo? and a limited time coral reef protection event in Solitaire Grand Harvest, both focused on extending engagement in existing titles. See our latest analysis for Playtika Holding. These content partnerships come as Playtika Holding’s share price shows mixed momentum, with a 12.14% 7 day share price return and a 24.47% 90 day...

In recent days, Immunovant reported that its FcRn inhibitor Batoclimab achieved clinically meaningful improvements in a Phase IIb trial for chronic inflammatory demyelinating polyneuropathy (CIDP), supporting its potential use in this difficult autoimmune condition. This progress in CIDP adds another possible indication to Immunovant’s FcRn pipeline, deepening its footprint in autoimmune neurology alongside a crowded field of emerging competitors. Next, we’ll examine how Batoclimab’s...

NCR Atleos recently announced that Global Credit Union has deployed its self-service ATMs at a new branch in Utqiagvik, Alaska, one of the most remote and extreme environments in the United States. This deployment underscores NCR Atleos’ ability to support reliable self-service banking in geographically isolated regions where infrastructure, weather, and logistics are especially challenging. We’ll now examine how NCR Atleos’ role in enabling remote self-service banking access in Utqiagvik...

Palladyne AI recently secured two U.S. Army contracts to research, develop, and operationally validate its SwarmOS and Gremlin-X systems with 4th Infantry Division warfighters, alongside integrating SwarmOS into the Army’s Next-Generation Command and Control ecosystem and showcasing capabilities at large-scale exercises like Northern Strike 26-2. By pairing these embodied AI and swarming validations with an exclusive U.S. production partnership for Israel Aerospace Industries’ HARPY, HAROP,...

If you are wondering whether Booking Holdings stock looks attractively priced after a mixed run, the current setup offers plenty of valuation questions worth unpacking. The share price recently closed at US$171.78, with the stock up 5.0% over the last week and 11.2% over the last month. It is still down 19.3% year to date and 18.1% over the past year, which can change how investors view both its potential and its risks. The latest move in Booking Holdings stock comes as investors react to...

FreeCast (CAST) stock has been back in focus after the company paired an expanded DIRECTV distribution deal with a new reseller agreement for Starlink Business connectivity, positioning its platform around bundled entertainment and broadband services. See our latest analysis for FreeCast. Those DIRECTV and Starlink Business announcements have coincided with extreme trading swings, with FreeCast’s share price return over the past week up more than 7x, the 30 day share price return above 260%,...

With the Federal Reserve holding rates at 3.5–3.75% and signaling that higher inflation could stick around longer than many expected, attention often turns to areas of the market that are tied to everyday essentials. Consumer staples stocks can sometimes offer a different risk and return profile to more cyclical areas when economic signals are mixed. This article looks at how that backdrop and the latest Fed commentary might affect a select group of large consumer staples companies, and...

AI is rapidly reshaping how work gets done, with top adopters reporting productivity growth of 163% and turning that into both higher wages and more hiring. That shift is raising the bar for human skills, especially in roles that rely on judgment, leadership, and creativity, and it is forcing companies to rethink how they train and develop talent. For investors, that puts Human Capital Development & Training Providers under the spotlight, as their services sit close to this skills...

Akso Health Group (AHG) recently reported a substantial jump in quarterly revenue alongside improved net profit. However, weak operating efficiency, financial health concerns, and limited disclosures are keeping investors focused on the durability of this shift. See our latest analysis for Akso Health Group. Despite the recent revenue headline, Akso Health Group’s share price has come under pressure, with a 30 day share price return down 17.79% and a 90 day share price return down 43.22%,...

Krystal Biotech (NasdaqGS:KRYS) reports strong revenue growth alongside progress in its rare disease pipeline. The company highlights ongoing clinical development for genetic therapies, including VYJUVEK for dystrophic epidermolysis bullosa. Recent updates focus on broader pipeline advancement in rare genetic conditions with high unmet medical need. Krystal Biotech enters the spotlight as investors track fresh updates on its revenue trajectory and expanding genetic therapy pipeline. The...